Current Concepts and Treatment of Langerhans’ Cell Histiocytosis
- 1 January 1992
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Langerhans Cell HistiocytosisNew England Journal of Medicine, 1987
- Histiocytosis X Langerhans Cells React with Antiinterleukin-2 Receptor Monoclonal AntibodyPediatric Pathology, 1987
- Histiocytosis X. Purified (T6+) cells from bone granuloma produce interleukin 1 and prostaglandin E2 in culture.Journal of Clinical Investigation, 1986
- Bone marrow involvement in histiocytosis XMedical and Pediatric Oncology, 1983
- Histiocytosis X—an analysis of prognostic factorsThe Journal of Pediatrics, 1975
- Chemotherapy of reticuloendotheliosis:Comparison of methotrexate plus prednisone vs. vincristine plus prednisoneCancer, 1974
- Histiocytosis X: Role of Radiation Therapy in Management with Special Reference to Dose Levels EmployedRadiology, 1973
- Prognosis in reticuloendotheliosis in childrenThe Journal of Pediatrics, 1962
- Die Reiticuloendotheliose — ein neues Krankheitsbild unter den HepatosphlenomegalienEuropean Journal of Pediatrics, 1933
- DEFECTS OF MEMBRANOUS BONES, EXOPHTHALMOS AND POLYURIA IN CHILDHO0DThe Lancet Healthy Longevity, 1921